Medford, MA, United States of America

Akos Czibere

USPTO Granted Patents = 2 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
2 patents (USPTO):

Title: Akos Czibere: Innovator in Cancer Therapy Optimization

Introduction

Akos Czibere, an accomplished inventor based in Medford, MA, has made significant contributions to the field of cancer therapy. With a total of two patents, he focuses on improving patient outcomes through innovative methods that tailor treatments according to specific biomarkers.

Latest Patents

His latest patents revolve around biomarker profiles that predict the outcomes of cancer therapy involving ERBB3 inhibitors and chemotherapies. These patents provide methods for optimizing therapy, treating patients, and selecting individuals who are likely to benefit from specific cancer treatments. For example, his patented methods allow for the identification of patients who will gain from treatment with an ErbB3 inhibitor, with or without an accompanying chemotherapeutic agent such as a taxane or an aromatase inhibitor. His approach is based on evaluating levels of particular biomarkers measured in biological samples, including biopsy sections. The identified biomarkers, which may encompass proteins and nucleic acids, play a key role in ErbB-mediated signal transduction.

Career Highlights

Akos Czibere is currently associated with Merrimack Pharmaceuticals, Inc., a company dedicated to advancing cancer therapies. Throughout his career, he has focused on innovations that intersect technology and healthcare, doing remarkable work to enhance cancer treatment methodologies.

Collaborations

In his professional journey, Akos has collaborated with notable colleagues including Bambang Adiwijaya and William Kubasek. Their joint efforts have contributed to the successful development of transformative treatment methods that benefit cancer patients.

Conclusion

Akos Czibere's innovative work in the realm of cancer therapy places him at the forefront of medical advancements. His commitment to optimizing treatment through biomarker analysis reflects a significant step toward personalized medicine. As he continues his research and development in this critical area, the impact of his inventions is expected to resonate throughout the medical community and beyond, enriching the lives of countless patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…